In comparison, anti-PD1 treatment demonstrated a modest 43% reduction in tumor burden which did not reach statistical significance.
← all excerpts
ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts.
1
—
—